Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis

被引：0
|
作者：
Garza-Elizondo, Angel Kevin [1 ]
Oscherwitz, Max [2 ]
Cervantes-Ramirez, Valeria [1 ]
Salazar-Marentes, Enrique [1 ]
Galarza-Delgado, Dionicio Angel [1 ]
Cardenas-de la Garza, Jesus Alberto [1 ]
机构：
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Rheumatol Dept, Monterrey, Mexico
[2] Wake Forest Sch Med, Ctr Dermatol Res, Dept Dermatol, Winston Salem, NC USA
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2024年 / 27卷 / 10期
关键词：
D O I：
10.1111/1756-185X.15365
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Iatrogenic Kaposi sarcoma during tumor necrosis factor alpha inhibitors
    Guglielmo, Alba
    Bertuzzi, Clara
    Scaioli, Eleonora
    Belluzzi, Andrea
    Sabattini, Elena
    Patrizi, Annalisa
    Pileri, Alessandro
    [J]. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (01) : 113 - 114
  • [2] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [3] Role of Tumor Necrosis Factor-Alpha in Rheumatoid Arthritis
    Link, Tina
    Kepner, Alisa
    Coruso, Olivia
    Dilip, Megha
    Jacobson, Reagan
    Stanovski, Lisa
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [4] Drug Retention of Tumor Necrosis Factor Inhibitors Compared to Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis
    Blagrove, Malcolm
    Pope, Janet
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1070 - 1070
  • [5] Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
    Nair, Shaalina
    Kahlon, Simranjit Singh
    Sikandar, Rabia
    Peddemul, Aishwarya
    Tejovath, Sreedevi
    Hassan, Danial
    Patel, Khushbu K.
    Mostafa, Jihan A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [6] Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R. Mikuls
    Arthur L. Weaver
    [J]. Current Rheumatology Reports, 2003, 5 (4) : 270 - 277
  • [7] Characterization of the treatment of rheumatoid arthritis for patients prescribed tumor necrosis factor-alpha inhibitors
    Stockl, K
    Jarrar, M
    Tandon, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 245 - 245
  • [8] Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis
    Semerano, Luca
    Assier, Eric
    Delavallee, Laure
    Boissier, Marie-Christophe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (04) : 545 - 550
  • [9] Iatrogenic Kaposi Sarcoma Precipitated by AntiTumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy
    Mariappan, Aathi Lakshmi
    Desai, Shreya
    Locante, Alberto
    Desai, Palak
    Quraishi, Javairia
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [10] Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis
    Fang, Yao-Fan
    Liu, Jia-Rou
    Chang, Shu-Hao
    Kuo, Chang-Fu
    See, Lai-Chu
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (11) : 1254 - 1262
12345